Arnold Ventures: How A Philanthropy Helped Tip The Scales In US Drug Pricing Debate
Executive Summary
A review of grants by the organization to a range of recipients engaged in work on lowering drug prices.
You may also be interested in...
340B And Innovation: Study Says Hospitals Keeping Rx Payments That Could Otherwise Fuel Drug R&D
Funded in part by Arnold Ventures, the NEJM study offers more data supporting the Rx industry’s call for 340B reform, and another perspective on how the savings could be used to benefit patients.
Pricing Reform Advocates Poised For ‘Rearguard Action’ By Industry If Legislation Prevails
Patient advocates are optimistic that ‘historic bill’ establishing price negotiation, inflation rebates and a spending cap in Medicare will pass into law.
ICER Extends Influence Among US Insurers With AHIP Subscription Deal
AHIP arrangement is a big win for ICER and will facilitate access to the organization’s cloud-based cost effectiveness review platform for a broad range of payers, particularly small and mid-size companies that may not have the resources to subscribe to the service on their own.